Markets

Wednesday 8/26 Insider Buying Report: JBGS, CNSP

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.

On Monday, JBG SMITH Properties' Director, Robert Alexander Stewart, made a $1.00M purchase of JBGS, buying 36,500 shares at a cost of $27.52 each. So far Stewart is in the green, up about 1.8% on their purchase based on today's trading high of $28.03. JBG SMITH Properties is trading down about 0.1% on the day Wednesday. This purchase marks the first one filed by Stewart in the past year.

And also on Monday, Chief Financial Officer Christopher Downs purchased $289,680 worth of CNS Pharmaceuticals, purchasing 142,000 shares at a cost of $2.04 a piece. CNS Pharmaceuticals is trading up about 17.4% on the day Wednesday. Downs was up about 39.7% on the buy at the high point of today's trading session, with CNSP trading as high as $2.85 in trading on Wednesday.

VIDEO: Wednesday 8/26 Insider Buying Report: JBGS, CNSP

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

JBGS CNSP

Other Topics

Stocks

Latest Markets Videos

    BNK Invest

    BNK Invest Inc. provides investment services and information. BNK Invest owns and operates a market news family of websites including DividendChannel, ETFChannel, StockOptionsChannel, and others, which make up an investor community featuring stock message boards, ratings, research, and strategies. BNK Invest caters to investing firms and individual investors internationally.

    Learn More